The Clarithromycin Prices had taken an irregular trajectory in the North American region by the conclusion of the fourth quarter of 2022. In the first two months of Q4, prices were observed to be constant in the upper range due to strong market demand sentiments and favorable cost support from the operational side. Additionally, the supply-demand imbalance and regional inflation contributed to an increase in the price of Clarithromycin API. However, due to low demand and ample supply, prices began to decline later in December as inflation began to reduce. Towards the termination of Q4 2022, the values accessed at USD 261500/MT with an average quarterly inclination of 0.31%.
For more information
E-Mail:- sales@chemanalyst.com
websites:- https://www.chemanalyst.com/Pricing-data/clarithromycin-1387
Contact No:- +13322586602
